The Multiple Myeloma Research Foundation (MMRF) was established in 1998 as non-profit organization by identical twin sisters Kathy Giusti and Karen Andrews soon after Kathy’s diagnosis of multiple myeloma.  At the time of Kathy’s diagnosis, no new treatments had been developed in decades, and the treatments that did exist weren’t very effective.  Kathy and Karen set out to create a patient-centered model of collaboration, and to find a cure for multiple myeloma.

Today, the MMRF is the world’s leading private funder of multiple myeloma research, and has raised over $275 million since 1998.  Nearly 90% of the MMRF’s total budget goes directly to research and related programming.  Thanks to the important work of the MMRF, the FDA has approved six new treatments, including two in just the past 24 months – a track record that’s unparalleled in the world of oncology.  These drugs have doubled the lifespan of myeloma patients.  And now the MMRF is funding 21 additional treatments in various stages of development, giving hope to tens of thousands of patients and their families.

To Learn More About The Multiple Myeloma Research Foundation…

Please visit the MMRF website.